糖化血紅蛋白 (HbA1c) 檢測的全球市場，預測到 2028 年

Global Hemoglobin A1C Testing Market, Forecast to 2028

出版日期: 2023年10月20日 | 出版商:

Frost & Sullivan | 英文 78 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

透過資料驅動的見解和創新分析為您的血紅蛋白 A1c ( 主導) 測試決策提供支持

由於技術進步和床邊檢測 (POCT) 的日益普及，預計全球 HbA1c 檢測市場將顯著成長。即時血糖監測和傳統的 HbA1c 測試相結合，透過提供最佳的治療選擇和更好的結果來徹底改變患者照護。這種整合簡化了資料收集並提高了醫療保健環境中的業務效率。 POCT 選項也發揮重要作用，現場 HbA1c 檢測可提供快速結果和快速反應時間，進一步提高患者滿意度並節省寶貴的資產。

醫療設備製造商、醫療保健 IT 提供者和製藥公司之間的合作將決定 HbA1c 測試市場的競爭形勢。這些合作夥伴關係透過促進行業融合和整合解決方案的開發，使公司成為擁有尖端產品的市場領導。階段利用這一趨勢的公司將比競爭獲得優勢，並透過滿足對綜合糖尿病管理產品日益成長的需求來創造新的業務前景。

主要競爭
2021 年世界糖尿病要點
2021-2045 年糖尿病患者人數
成人患者數量排名前 10 名的國家/地區
成長指標
生長促進因子
成長抑制因素
預測假設
收益預測
收益預測分析
按地區分類的收益預測
按地區分類的收益預測分析
按環境分類的收益預測
按環境分類的收益預測分析
按最終用戶分類的收益預測
按最終用戶分類的收益預測分析
按技術分類的收益預測
按技術分類的收益預測分析
價格趨勢與分析
玩家採取的主要定價策略
未來價格展望
全球 HbA1c 檢測市場：值得注意的活動
全球 HbA1c 檢測報銷途徑
競爭環境

值得關注的公司：實驗室/POCT HbA1c 檢測

特色公司：雅培實驗室
特色公司：羅氏診斷
特色公司：西門子醫療
特色公司：貝克曼庫爾特
特色公司：東曹株式會社
特色公司：Bio-Rad 實驗室
特色公司：EKF 診斷
特色公司：Erba Diagnostics, Inc.
特色公司：Diazyme Laboratories
特色公司：PTS 診斷公司
特色公司：三一生物科技
競爭映射，由 HbA1c 提供的參數

成長機會宇宙

成長機會概覽
成長機會 1：根據患者個體特徵客製化 HbA1c 檢測方法
成長機會 2：POCT 進步，實現準確、經濟且使用者友好的 HbA1c 檢測
成長機會 3：抓住不斷成長的糖尿病照護市場的機會
成長機會 4：糖尿病 HbA1c 篩檢以實現最佳護理和管理

下一步

簡介目錄

Product Code: K960-55

Utilizing Data-driven Insights and Innovative Assays for Enhanced Decision-making in Hemoglobin A1C Testing

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets.

Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products. Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the HbA1c Testing Industry
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of the Study
Segmentation by Setting
Segmentation by End Users
Segmentation by Technology

HbA1c Testing Overview

Key Competitors
Global Diabetes Highlights, 2021
Number of People with Diabetes, 2021-2045
Top 10 Countries or Territories for Number of Adults
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Region
Revenue Forecast Analysis by Region
Revenue Forecast By Setting
Revenue Forecast Analysis by Setting
Revenue Forecast by End Users
Revenue Forecast Analysis by End Users
Revenue Forecast by Technology
Revenue Forecast Analysis by Technology
Pricing Trends and Analysis
Key Pricing Strategies Adopted by Players
Future Aspect of Pricing
Global HbA1c Testing Market-Notable Activities
Global HbA1c Testing Reimbursement Pathways
Competitive Environment

Companies to Watch-Lab and POC HbA1c Testing

Companies to Watch-Abbott Laboratories
Companies to Watch-Roche Diagnostics
Companies to Watch-Siemens Healthineers
Companies to Watch-Beckman Coulter
Companies to Watch-Tosoh Corporation
Companies to Watch-Bio-Rad Laboratories
Companies to Watch-EKF Diagnostics
Companies to Watch-Erba Diagnostics, Inc.
Companies to Watch-Diazyme Laboratories
Companies to Watch-PTS Diagnostics
Companies to Watch-Trinity Biotech
Competitive Mapping by HbA1c Offering Parameters

Growth Opportunity Universe

Growth Opportunity Summary
Growth Opportunity 1-Tailoring HbA1c Testing Approaches to Individual Patient Characteristics
Growth Opportunity 2-Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing
Growth Opportunity 3-Capturing Opportunities in Growing Diabetes Care Markets
Growth Opportunity 4-Diabetes HbA1c Screening for Better Care and Management